BP Limb Length of 60cm vs 100cm in Roux-en-Y Gastric Bypass
NCT ID: NCT04377230
Last Updated: 2020-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
200 participants
INTERVENTIONAL
2020-05-07
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Group 60: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 60cm
* Group 100: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 100cm
Bone mineral density will be evaluated before surgery and 2 years after it.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Biliopancreatic Limb Lenght on Long-term Weight Loss After Roux-en-Y Gastric Bypass
NCT03607305
RYGB AL 150cm BPL 100cm vs RYGB AL 100cc BPL 150cm
NCT03838276
Gastric Bypass With Different Lengths of the Bilipancreatic Limb
NCT05334173
The Effect of Roux-en-Y Gastric Bypass on Bone Turnover
NCT03046147
Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery
NCT06756789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Group 60: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 60cm
* Group 100: Patients will undergo a Roux-en-Y gastric bypass with a Biliopancreatic limb length of 100cm Alimentary limb will be constant in both groups (150cm length)
Bone mineral density will be evaluated before surgery and 2 years after it, by means of X ray absorptiometry (DEXA). Changes in bone mineral density in lumbar column will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biliopancreatic limb 60cm
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 60cm.
biliopancreatic limb length of 60cm.
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 60cm.
Biliopancreatic limb 100cm
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 100cm.
biliopancreatic limb length of 100cm.
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 100cm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biliopancreatic limb length of 60cm.
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 60cm.
biliopancreatic limb length of 100cm.
Roux-en- Y gastric bypass will be performed with a biliopancreatic limb length of 100cm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index \>35 Kg/m2 associated to obesity related comorbidities
Exclusion Criteria
* Active neoplasms
* Disorders in calcium or vitamin D metabolism
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Seguridad Social del Estado de Mexico y Municipios
OTHER_GOV
Hospital General Universitario Elche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaime Ruiz-Tovar, MD, PhD
Department of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaime Ruiz-Tovar
Role: PRINCIPAL_INVESTIGATOR
Garcilaso Clinic
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Garcilaso-Mex 20-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.